tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Roman, 39 are a BUY (39.39%), 48 are a HOLD (48.48%), 12 are a SELL (12.12%).
Analyst David Roman, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 55.77% that have a potential upside of 14.98% achieved within 170 days.
David Roman’s has documented 192 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BAX, Baxter International at 15-Jul-2026.
Analyst best performing recommendations are on HQY (HEALTHEQUITY).
The best stock recommendation documented was for HQY (HEALTHEQUITY) at 1/9/2026. The price target of $89 was fulfilled within 3 days with a profit of $5.15 (5.47%) receiving and performance score of 18.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Oct-2025
$21
$-1.4 (-6.25%)
$17
16 days ago
(15-Jul-2026)
4/8 (50%)
$-1.15 (-5.19%)
65
Buy Since 25-May-2022
$24
$1.6 (7.14%)
$22
25 days ago
(06-Jul-2026)
7/16 (43.75%)
$1.42 (6.29%)
311
Hold Since 13-Feb-2023
$17
$-5.04 (-22.87%)
$19
2 months 3 days ago
(28-May-2026)
9/24 (37.5%)
$-2.25 (-11.69%)
245
Buy Since 18-Dec-2018
$27
$4.96 (22.50%)
$25
2 months 27 days ago
(04-May-2026)
5/23 (21.74%)
$10.38 (62.45%)
376
Sell Since 05-May-2025
$15
$-7.04 (-31.94%)
$27
7 months 29 days ago
(02-Dec-2025)
5/6 (83.33%)
$-3.83 (-20.34%)
73
Which stock is David Roman is most bullish on?
Which stock is David Roman is most reserved on?
What Year was the first public recommendation made by David Roman?
